期刊文献+

弥漫性大B细胞淋巴瘤中C-MYC蛋白表达与基因异常的相关性 被引量:3

Correlation between C-MYC protein expression and genetic abnormalities in diffuse large B-cell lymphoma
原文传递
导出
摘要 目的探讨弥漫性大B细胞淋巴瘤(DLBCL)中癌基因C-MYC蛋白表达及与基因异常的相关性。方法回顾性收集山东省潍坊市人民医院病理科2015年1月至2016年10月首次诊断为DLBCL的石蜡包埋组织标本42例,采用免疫组织化学和荧光原位杂交(FISH)技术检测全部研究对象组织标本中C-MYC蛋白表达与基因异常的情况,观察两者之间的相关性。结果C-MYC蛋白表达阳性率为47.6%(20/42);C-MYC基因异常检出率为26.2%(11/42),其中基因易位检出率23.8%(10/42);基因扩增2.4%(1/42);C-MYC蛋白表达阳性与C-MYC基因易位有相关性(χ2=11.813;P=0.001);C-MYC基因易位主要见于生发中心B细胞型(χ2=4.029;P=0.045)。结论C-MYC蛋白表达阳性(≥40%)与C-MYC基因易位有相关性。在DLBCL中,C-MYC蛋白高表达提示可能存在C-MYC基因易位。 ObjectiveTo study the correlation between expression of oncogene C-MYC protein and gene abnormality in diffuse large B-cell lymphoma (DLBCL).MethodsThe expression of C-MYC protein and gene abnormality were detected by immunohistochemistry and fluorescence in situ hybridization (FISH), respectively, in 42 cases of paraffin-embedded DLBCL. All cases were collected at Department of Pathology, Weifang People′s Hospital during January 2015 to October 2016.ResultsThe positive rate of C-MYC protein expression was 47.6% (20/42) and the rate of abnormal C-MYC gene by FISH was 26.2%(11/42), including translocation (23.8%, 10/42) and gene amplification (2.4%, 1/42). There was a close relationship between the protein expression and gene translocation (χ2=11.813; P=0.001) and gene translocation occurred primarily in GCB (χ2=4.029; P=0.045).ConclusionThe high expression (≥40%) of C-MYC protein is associated with its gene translocation, suggesting that C-MYC protein detection can be used as a surrogate marker for C-MYC gene translocation in DLBCL.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2018年第3期172-175,共4页 Chinese Journal of Pathology
基金 山东省科技攻关项目(2015GSF118168) 潍坊市发展计划课题(20100220)
关键词 淋巴瘤 大B-细胞 弥漫性 原癌基因蛋白质C-MYC 基因扩增 Lymphoma, large B-cell, diffuse Proto-oncogene proteins c-myc Gene amplification
  • 相关文献

参考文献1

二级参考文献29

  • 1Gollub MJ. Imaging of gastrointestinal lymphoma[J]. Radiol Clin North Am, 2008, 46(2) :287-312.
  • 2Akyurek N, Uner A, Benekli M, et al. Prognostic significance of MYC, BCl2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab[J] . Cancer, 2012,118(17) :41734183.
  • 3Slack GW, Gascoyne RD. MYC and aggressive B-cell lymphomas[J]. Adv Anat Pathol, 2011, 18(3) :219-228.
  • 4Choi SY, Kim SJ, Kim WS, et al. Aggressive B cell lymphomas of the gastrointestinal tract: clinicopathologic and genetic analysis[J]. Virchows Arch, 2011 , 459 (5) :495-502.
  • 5ArmitageJO. Staging non-Hodgkin lymphoma[J]. CA CancerJ Clin, 2005, 55 (6) : 368-376.
  • 6Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray[J]. Blood, 2004, 103 ( 1 ) :275-282.
  • 7Rodig SJ, VergilioJA, Shahsafaei A, et al. Characteristic expression patterns of TCLl, CD38 , and CD44 identify aggressive lymphomas harboring a MYC translocation[J]' AmJ Surg Pathol, 2008, 32(1) : 113-122.
  • 8Green TM, Nielsen 0, de Stricker K, et al. High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-celilymphoma[J]. AmJSurgPathol, 2012, 36(4) :612- 619.
  • 9Ventura RA,Martin-SuberoJI,Jones M, et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue] J].J Mol Diagn, 2006, 8(2): 141-151.
  • 10Barton S, Hawkes EA, Wotherspoon A, et al. Are we ready to stratify treatment for diffuse large B-celllymphoma using molecular hallmarks?[J]. Oncologist, 2012, 17 (12) : 1562-1573.

共引文献4

同被引文献24

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部